Accretion Nutraveda IPO is scheduled to list on 04 Feb 2026 on NSE, BSE.
Listed
SME IPO
ACCRETIONNUTRAVEDA
Accretion Nutraveda IPO Listing Price Today
Accretion Nutraveda IPO listed on 04 Feb 2026 at ₹191 against an issue price of ₹129, a listing gain of +48.06%.
- Issue price
- ₹129
- Actual listing price
- ₹191
- Listing Date
- 04 Feb 2026
- Exchange
- NSE, BSE
Live share price
Accretion Nutraveda share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Accretion Nutraveda listing price vs GMP estimate
| Issue price | ₹129 |
|---|---|
| Latest GMP | ₹62 (+48.06%) |
| Expected listing price (issue price + GMP) | ₹191 |
| Actual listing price | ₹191 |
| Listing gain | +48.06% |
| Difference from GMP estimate | +₹0 (+0.00%) |
Profit per application
₹1,24,000
At the listing price, for 2,000 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (35.6% of SME IPOs opened within 10% of their GMP estimate).
View Research Report →
GMP trend
Accretion Nutraveda GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 04 Feb 2026 | ₹69.00 | +53 |
| 03 Feb 2026 | ₹16.00 | +10 |
| 02 Feb 2026 | ₹6.00 | - |
Listing day
Listing day timings
| Listing Date | 04 Feb 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
Accretion Nutraveda IPO: frequently asked questions
Accretion Nutraveda IPO listed at ₹191 against an issue price of ₹129, a listing gain of +48.06%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Accretion Nutraveda shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
At the listing price, one minimum application of 2,000 shares in Accretion Nutraveda IPO made about ₹1,24,000.